Developer docs
API playgroundTry for free, no card

Search company profiles

Qlucore

Full company profile

uuid00028ij

Namestring
Qlucore
Legal namestring
Qlucore AB
Websiteurl
qlucore.com
Company typeenum
Public
Founded yearint
2007
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLund, Sweden
HQ citystring
Lund
HQ countrystring
Sweden
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
bioinformatics software, multi-omics data analysis, clinical diagnostics software, precision medicine analytics, gene expression visualization
Industry4 codes
PRIMARYHLAGAJAD
Bioinformatics & Multi-omics Analysis Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAF
Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGANAI
Bioinformatics, Multi-Omics Data Analysis & Interpretation Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
NAICS code2 codes
  • Software Publishers5132
  • Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services518210
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Computer Programming, Data Processing, Etc.7370
Product category
Bioinformatics Software
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Software Licenses and Subscriptions
TypeSubscription Recurring
Description

Qlucore generates revenue through software licensing of Qlucore Omics Explorer and Qlucore Insights, with subscription-based pricing models. The company offers free trials for evaluation purposes.

qlucore.com
2Clinical Diagnostics Software
TypeSubscription Recurring
Description

Qlucore Diagnostics generates revenue from CE-marked IVDR-certified diagnostic tests sold to clinical laboratories and hospitals for clinical cancer diagnostics.

qlucore.com
3Cloud Services
TypeSubscription Recurring
Description

Cloud-based access to Qlucore Omics Explorer with computational power and centralized data storage, offered in Standard, Performance, and NGS packages.

qlucore.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations
Pricing details2 tiers
1Free trial available for evaluation
ModelFreemiumBilling cadenceOthers
Notes

Qlucore offers free trials for Qlucore Omics Explorer and Qlucore Insights, allowing users to download and test the software before purchase.

qlucore.com
2Cloud packages with computational power and storage
ModelSubscriptionBilling cadenceMonthly
Notes

Three cloud packages available: Standard (for most omics data including RNA-seq, 20GB storage), Performance (for single cell RNA-seq and large datasets, 50GB storage), and NGS (for omics, NGS data and genomic analysis). Specific pricing requires contacting the company.

qlucore.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 3 records shown
1Qlucore Omics Explorer
Description

Powerful, flexible and easy-to-use visualization of multi-omics data for fast analysis and results. Used by researchers and pharmaceutical companies worldwide.

qlucore.com
+2 more records
Core offering1 text field

Qlucore develops and sells visualization-based bioinformatics software for multi-omics data analysis and clinical cancer diagnostics. Its product family spans Qlucore Omics Explorer (desktop/cloud research software with interactive visualization and integrated statistics), Qlucore Insights (research-use AI classifiers and gene fusion detection for cancer subtyping), and Qlucore Diagnostics (CE-marked IVDR-certified clinical diagnostic software). The company also offers AWS-hosted cloud deployment of its software.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Up to 7% more samples covered compared to standard methods in BCP-ALL through detection of DUX4-rearranged and ETV6::RUNX1-like subtypes
+4 more records
Product overview1 text field

Qlucore offers a three-tier product portfolio centered on visualization-based bioinformatics software for omics research and precision diagnostics. The flagship platform is Qlucore Omics Explorer, a desktop and cloud software enabling multi-omics data analysis with interactive visualizations, integrated statistics (DESeq2, ANOVA, t-tests), machine learning classifiers, and a Python-based Templates scripting system, with an optional NGS Module add-on for genome browsing and fusion analysis. On top of this platform, Qlucore Insights (Research Use Only) provides disease-specific AI-powered classifiers and gene fusion detection for four cancer types: BCP-ALL, AML, lung cancer, and urothelial (bladder) cancer — each available as separate disease models within the same software. The third tier, Qlucore Diagnostics, is the CE-marked IVDR-certified clinical version, with the first product being the Qlucore Diagnostics BCP-ALL test for pediatric leukemia, while AML and bladder cancer tests remain under development. All products are sold as software licenses with optional cloud deployment on AWS.

Product and service4 records
1Qlucore Omics Explorer
CategoryBioinformatics software platform
Description

Powerful, flexible, and easy-to-use visualization-based software for multi-omics data analysis, supporting genomics, proteomics, transcriptomics, and single-cell data. It features real-time interactive plots (PCA, UMAP, t-SNE, heatmaps, volcano plots, violin plots), integrated DESeq2 statistics, machine learning classifiers, Python-based Templates scripting, and optional cloud deployment. It is used by researchers and pharmaceutical companies across 20-25 countries.

2Qlucore Insights
CategoryResearch-use disease classification software
Description

Disease-specific research-use-only (RUO) software platform combining AI-based machine learning classifiers with gene fusion detection for tumor subtype classification. Supports models for BCP-ALL, AML, lung cancer, and urothelial (bladder) cancer, providing automated PDF reports with results, plots, quality metrics, and method information for researchers and pharmaceutical users.

3Qlucore Diagnostics
CategoryClinical in vitro diagnostic software
Description

IVDR-certified (CE-marked) in vitro diagnostic software for clinical use in hospitals. The first product is Qlucore Diagnostics BCP-ALL, a CE-marked RNA-seq based diagnostic test for pediatric Acute Lymphoblastic Leukemia, providing gene expression subtype classification and gene fusion analysis support. CE-marked tests for AML and bladder cancer are in development. Sold directly to hospitals and clinical diagnostic laboratories.

4Qlucore Cloud Services
CategoryCloud-hosted bioinformatics software
Description

Cloud-hosted deployment of Qlucore Omics Explorer accessible from any internet-connected device, operated on Amazon Web Services (AWS). Available packages include Standard (for most omics data including RNA-seq, 20GB storage), Performance (for single cell RNA-seq, 50GB storage), and NGS (for omics, NGS, and genomic analysis). Sold as monthly subscriptions.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
1Rigshospitalet, Denmark
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-06-11
Description

Denmark's largest teaching and public hospital uses Qlucore Diagnostics BCP-ALL for clinical diagnostics of pediatric leukemia. Rigshospitalet was an early adopter, transitioning from Qlucore Insights RUO to the CE-marked IVDR-compliant solution.

qlucore.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-01-01
Description

Collaboration through Eurostars program resulted in lung classifier model for AI-based lung cancer subtyping. Results presented as poster at MAP Congress 2024 in London, demonstrating high accuracy in analyzing lung tumors and lung diseases.

Strategic tierMinorTypeOthers
Description

Certified Advisor for Qlucore's listing on Nasdaq First North Growth market. Located at Nybrogatan 34, 102 45 Stockholm, Sweden.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Provides a genomics and multi-omics analytics platform for research, pharma, and clinical customers, including pipelines for RNA-seq and cancer analysis. Comparable to Qlucore's platform plus Insights/Diagnostics portfolio.

TypeDirect peer
Description

Enterprise bioinformatics platform for omics data analysis, biopharma R&D workflows, and large-scale screening. Comparable to Qlucore as a specialist omics-software vendor targeting pharma/biotech customers with sophisticated analytics.

TypeBroad incumbent
Description

Major life sciences tools and informatics company offering Ion Torrent, Oncomine assays, and bioinformatics/analytics tools. A broad incumbent competing with Qlucore across research and clinical oncology workflows.

TypeBroad incumbent
Description

Dominant NGS instrument and informatics provider with DRAGEN, BaseSpace, and connected analytics offerings. A broad incumbent that competes with Qlucore's software across research and clinical genomics customers.

5BlueBee
TypeEmerging player
Description

Cloud bioinformatics and genomics data-analysis platform serving clinical and research labs across Europe. Comparable to Qlucore on cloud-delivered bioinformatics for regulated and research use.

TypeDirect peer
Description

Cloud-based biomedical data analysis and informatics platform supporting clinical and research genomics. Comparable to Qlucore on the cloud bioinformatics side, especially given Qlucore's AWS-based Cloud Hub offering.

TypeDirect peer
Description

Provides Partek Flow, a commercial bioinformatics software suite for NGS and multi-omics analysis with visualization and statistical workflows. Directly comparable to Qlucore Omics Explorer as a paid desktop/cloud bioinformatics platform serving research and pharma customers.

8PierianDx (now part of Philips)
TypeEmerging player
Description

Clinical genomics interpretation platform for oncology and hereditary disease, integrated into Philips' broader diagnostics portfolio. Comparable to Qlucore Diagnostics as a clinical genomics interpretation vendor focused on hospitals.

TypeEmerging player
Description

Cloud-based bioinformatics platform for genomics and multi-omics analysis aimed at research and translational customers. Comparable to Qlucore Omics Explorer Cloud as a SaaS-style omics analysis offering.

TypeDirect peer
Description

Offers the SOPHiA DDM platform for clinical genomics data analysis, including CE-IVD algorithms for cancer and rare disease. Directly comparable to Qlucore Diagnostics as a regulated, software-driven clinical genomics/diagnostic analytics vendor.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration9 records

Each record includes

Title, Type, Description, Source

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors5 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Qlucore

Bioinformatics Softwareqlucore.com

Qlucore firmographics

Firmographics
Name
Qlucore
Legal name
Qlucore AB
Website
https://qlucore.com
Company type
Public
Founded year
2007
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Qlucore industry classification

Industry
Product category
Bioinformatics Software
NAICS
Software Publishers (5132), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518210)
SIC
Services-Prepackaged Software (7372), Services-Computer Programming, Data Processing, Etc. (7370)
akta.pro industry
PRIMARYHLAGAJAD
Bioinformatics & Multi-omics Analysis Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAF
Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGANAI
Bioinformatics, Multi-Omics Data Analysis & Interpretation Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)

Keywords

  • Bioinformatics software
  • Multi-omics data analysis
  • Clinical diagnostics software
  • Precision medicine analytics
  • Gene expression visualization

Where Qlucore is headquartered

Location

Headquarters

HQ city
Lund
HQ country
Sweden
HQ region
Europe

Offices3 records

Markets served

Qlucore business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations

Revenue model

  1. Software Licenses and Subscriptions: Qlucore generates revenue through software licensing of Qlucore Omics Explorer and Qlucore Insights, with subscription-based pricing models. The company offers free trials for evaluation purposes.
  2. Clinical Diagnostics Software: Qlucore Diagnostics generates revenue from CE-marked IVDR-certified diagnostic tests sold to clinical laboratories and hospitals for clinical cancer diagnostics.
  3. Cloud Services: Cloud-based access to Qlucore Omics Explorer with computational power and centralized data storage, offered in Standard, Performance, and NGS packages.

Pricing tiers

ModelBillingPrice
FreemiumOthersFree trial available for evaluation
SubscriptionMonthlyCloud packages with computational power and storage

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Qlucore product offering

Product offering

Core offering

Qlucore develops and sells visualization-based bioinformatics software for multi-omics data analysis and clinical cancer diagnostics. Its product family spans Qlucore Omics Explorer (desktop/cloud research software with interactive visualization and integrated statistics), Qlucore Insights (research-use AI classifiers and gene fusion detection for cancer subtyping), and Qlucore Diagnostics (CE-marked IVDR-certified clinical diagnostic software). The company also offers AWS-hosted cloud deployment of its software.

Product overview

Qlucore offers a three-tier product portfolio centered on visualization-based bioinformatics software for omics research and precision diagnostics. The flagship platform is Qlucore Omics Explorer, a desktop and cloud software enabling multi-omics data analysis with interactive visualizations, integrated statistics (DESeq2, ANOVA, t-tests), machine learning classifiers, and a Python-based Templates scripting system, with an optional NGS Module add-on for genome browsing and fusion analysis. On top of this platform, Qlucore Insights (Research Use Only) provides disease-specific AI-powered classifiers and gene fusion detection for four cancer types: BCP-ALL, AML, lung cancer, and urothelial (bladder) cancer — each available as separate disease models within the same software. The third tier, Qlucore Diagnostics, is the CE-marked IVDR-certified clinical version, with the first product being the Qlucore Diagnostics BCP-ALL test for pediatric leukemia, while AML and bladder cancer tests remain under development. All products are sold as software licenses with optional cloud deployment on AWS.

Differentiator

Problem solved

Functional benefit

Brands

  • Qlucore Omics Explorer: Powerful, flexible and easy-to-use visualization of multi-omics data for fast analysis and results. Used by researchers and pharmaceutical companies worldwide.
  • Qlucore Insights
  • Qlucore Diagnostics

Products and services

  • Qlucore Omics Explorer Powerful, flexible, and easy-to-use visualization-based software for multi-omics data analysis, supporting genomics, proteomics, transcriptomics, and single-cell data. It features real-time interactive plots (PCA, UMAP, t-SNE, heatmaps, volcano plots, violin plots), integrated DESeq2 statistics, machine learning classifiers, Python-based Templates scripting, and optional cloud deployment. It is used by researchers and pharmaceutical companies across 20-25 countries.
  • Qlucore Insights Disease-specific research-use-only (RUO) software platform combining AI-based machine learning classifiers with gene fusion detection for tumor subtype classification. Supports models for BCP-ALL, AML, lung cancer, and urothelial (bladder) cancer, providing automated PDF reports with results, plots, quality metrics, and method information for researchers and pharmaceutical users.
  • Qlucore Diagnostics IVDR-certified (CE-marked) in vitro diagnostic software for clinical use in hospitals. The first product is Qlucore Diagnostics BCP-ALL, a CE-marked RNA-seq based diagnostic test for pediatric Acute Lymphoblastic Leukemia, providing gene expression subtype classification and gene fusion analysis support. CE-marked tests for AML and bladder cancer are in development. Sold directly to hospitals and clinical diagnostic laboratories.
  • Qlucore Cloud Services Cloud-hosted deployment of Qlucore Omics Explorer accessible from any internet-connected device, operated on Amazon Web Services (AWS). Available packages include Standard (for most omics data including RNA-seq, 20GB storage), Performance (for single cell RNA-seq, 50GB storage), and NGS (for omics, NGS, and genomic analysis). Sold as monthly subscriptions.

Quantifiable outcome

  • Up to 7% more samples covered compared to standard methods in BCP-ALL through detection of DUX4-rearranged and ETV6::RUNX1-like subtypes
  • +4 more outcomes

Companies that use Qlucore

Customer profile

Named customers6 records

Segments3 records

Ideal customer profiles3 records

Qlucore technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration9 records

AI capability3 records

Feature5 records

Qlucore partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • Rigshospitalet, DenmarkcoreTechnology or Integration · 11 June 2025Denmark's largest teaching and public hospital uses Qlucore Diagnostics BCP-ALL for clinical diagnostics of pediatric leukemia. Rigshospitalet was an early adopter, transitioning from Qlucore Insights RUO to the CE-marked IVDR-compliant solution.
  • Heidelberg University HospitalcoreStrategic or Co-development Partner · 1 January 2021Collaboration through Eurostars program resulted in lung classifier model for AI-based lung cancer subtyping. Results presented as poster at MAP Congress 2024 in London, demonstrating high accuracy in analyzing lung tumors and lung diseases.
  • FNCA Sweden ABminorOthersCertified Advisor for Qlucore's listing on Nasdaq First North Growth market. Located at Nybrogatan 34, 102 45 Stockholm, Sweden.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Qlucore competitors and assessment

Company assessment

Direct peers

  • Velsera (formerly Seven Bridges Genomics): Provides a genomics and multi-omics analytics platform for research, pharma, and clinical customers, including pipelines for RNA-seq and cancer analysis. Comparable to Qlucore's platform plus Insights/Diagnostics portfolio.
  • Genedata: Enterprise bioinformatics platform for omics data analysis, biopharma R&D workflows, and large-scale screening. Comparable to Qlucore as a specialist omics-software vendor targeting pharma/biotech customers with sophisticated analytics.
  • DNAnexus: Cloud-based biomedical data analysis and informatics platform supporting clinical and research genomics. Comparable to Qlucore on the cloud bioinformatics side, especially given Qlucore's AWS-based Cloud Hub offering.
  • Partek: Provides Partek Flow, a commercial bioinformatics software suite for NGS and multi-omics analysis with visualization and statistical workflows. Directly comparable to Qlucore Omics Explorer as a paid desktop/cloud bioinformatics platform serving research and pharma customers.
  • SOPHiA Genetics: Offers the SOPHiA DDM platform for clinical genomics data analysis, including CE-IVD algorithms for cancer and rare disease. Directly comparable to Qlucore Diagnostics as a regulated, software-driven clinical genomics/diagnostic analytics vendor.

Broad incumbents

  • Thermo Fisher Scientific: Major life sciences tools and informatics company offering Ion Torrent, Oncomine assays, and bioinformatics/analytics tools. A broad incumbent competing with Qlucore across research and clinical oncology workflows.
  • Illumina: Dominant NGS instrument and informatics provider with DRAGEN, BaseSpace, and connected analytics offerings. A broad incumbent that competes with Qlucore's software across research and clinical genomics customers.

Emerging players

  • BlueBee: Cloud bioinformatics and genomics data-analysis platform serving clinical and research labs across Europe. Comparable to Qlucore on cloud-delivered bioinformatics for regulated and research use.
  • PierianDx (now part of Philips): Clinical genomics interpretation platform for oncology and hereditary disease, integrated into Philips' broader diagnostics portfolio. Comparable to Qlucore Diagnostics as a clinical genomics interpretation vendor focused on hospitals.
  • ROSALIND (OnRamp Bioinformatics): Cloud-based bioinformatics platform for genomics and multi-omics analysis aimed at research and translational customers. Comparable to Qlucore Omics Explorer Cloud as a SaaS-style omics analysis offering.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Qlucore social profiles

Digital presence

Qlucore compliance and trust

Trust signal

Compliance3 records

Qlucore financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Qlucore leadership team

Management profile

Number of profiles

Profiles9 records

Qlucore funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Qlucore M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Qlucore

What does Qlucore do?

Qlucore develops and sells visualization-based bioinformatics software for multi-omics data analysis and clinical cancer diagnostics. Its product family spans Qlucore Omics Explorer (desktop/cloud research software with interactive visualization and integrated statistics), Qlucore Insights (research-use AI classifiers and gene fusion detection for cancer subtyping), and Qlucore Diagnostics (CE-marked IVDR-certified clinical diagnostic software). The company also offers AWS-hosted cloud deployment of its software.

Is Qlucore a public or private company?

Qlucore is a public company. It is classified as public and is currently operating.

When was Qlucore founded?

Qlucore was founded in 2007. It employs 11 to 50 people.

Where is Qlucore based?

Qlucore is headquartered in Lund, Sweden, in the Europe region.

How does Qlucore make money?

Three revenue lines are on record. Software Licenses and Subscriptions are the primary driver. The others are clinical Diagnostics Software and cloud Services.

Who are Qlucore's main competitors?

Direct peers on record are Velsera (formerly Seven Bridges Genomics), Genedata, DNAnexus, Partek and SOPHiA Genetics. Broad incumbents are Thermo Fisher Scientific and Illumina. Emerging players are BlueBee, PierianDx (now part of Philips) and ROSALIND (OnRamp Bioinformatics).

Does Qlucore have an API?

No public API is recorded for Qlucore.

What industry is Qlucore in?

Qlucore's product category is Bioinformatics Software. Its primary akta.pro industry code is HLAGAJAD, Bioinformatics & Multi-omics Analysis Software, with a secondary code of HLAGAJAF, Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D). Its NAICS code is 5132 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The future of tradingQlucore CEO Carl-Johan Ivarsson to step down around year-end 2026/2027Qlucore announced a CEO transition around year-end 2026/2027, launching a search for a new chief executive. Current CEO Carl-Johan Ivarsson will remain for roughly 3 to 6 months while a successor is recruited, with Chairman Lars Pålsson continuing to work closely with him until the new CEO takes over.PharmiWeb.comQlucore Receives Approval for 0.5M EUR Installment from the EUQlucore received a 0.5 million Euro installment from the EU after passing milestones in a 2.5 million Euro grant. The project aims to develop CE-marked software for clinical cancer diagnostics for acute myeloid leukemia and bladder cancer. The company plans to launch the software and collaborate with the pharmaceutical industry on companion diagnostics.FinansavisenQlucore Launches First CE-Marked Diagnostic Test for Pediatric LeukemiaQlucore Diagnostics launched the first CE-marked (IVDR) diagnostic test for pediatric leukemia, available for delivery and clinical use in Europe. The AI-based software analyzes gene expression to classify B-cell precursor acute lymphoblastic leukemia into six subtypes, aiding treatment decisions. Future tests for lung, acute myeloid, and bladder cancers are in development.PharmiWeb.comUppsala University Hospital chooses AI-based Qlucore Insights to develop precision diagnosticsQlucore signed an agreement with Uppsala University Hospital to use its AI-based Insights software for analyzing acute lymphoblastic leukemia in children. The hospital will use the software to improve diagnosis and treatment decisions, and the agreement is the second in Sweden in a short time.PharmiWeb.comQlucore starts project after receiving prestigious EU grant to advance personalized cancer treatmentQlucore received a 2.5 million Euro EIC Accelerator grant to develop clinical cancer diagnostics for acute myeloid leukemia and bladder cancer. The three-year project will produce CE-marked software for clinical laboratories and companion diagnostics with pharma companies. The grant follows a competitive selection process.QlucorePress releaseQlucore has received a 200,000 SEK grant from Vinnova through the Medtech4Health program to support the implementation of its medical technology solutions in cancer care. The company is currently testing four classification models for leukemia, lung, and bladder cancers, with plans to launch its CE-marked diagnostic product, Qlucore Diagnostics, in 2025.PharmiWeb.comQlucore recognized by strategic innovation program for MedTechQlucore has received a SEK 200,000 grant from the innovation agency Vinnova through the Medtech4Health strategic innovation program to enhance data security for its upcoming diagnostic software. The project supports Qlucore Diagnostics, which is scheduled to launch in 2025 as a CE-marked in vitro diagnostic medical device for clinical use in hospital laboratories. This funding aims to improve personalized cancer treatment by enabling more precise classification of cancer types into subgroups.Nordic 9Qlucore secured SEK 30 million in a pre-IPO private placement led by Eiffel Investment Group.Qlucore, a Swedish healthcare analytics SaaS firm, completed a SEK 30 million ($3.4M) pre-IPO round led by Eiffel Investment Group. Proceeds will accelerate sales and technical expansion before a planned IPO on the local stock exchange within twelve months. The company, founded in 2007, has over 200 customers and expects cancer diagnostics to drive future growth.PrwebQlucore Webinar Presents User-Friendly Omics ExplorerQlucore is hosting a free webinar on May 17, 2016, to discuss its Omics Explorer software, which allows biologists to explore data sets without bioinformatics expertise. The software uses visualization and statistical methods, and the webinar will be presented by Qlucore's president and a professor.